AC
AGN

Andromeda Capital’s Allergan plc AGN Stock Holding History

Andromeda Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-62,900
Closed -$9.06M – 118
2013
Q3 		$9.06M Sell
62,900
-42,500
-40% -$5.66M 1.12% 23
2013
Q2 		$13.3M Buy
+105,400
New +$11.9M 1.86% 16

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Andromeda Capital's AGN Position: Q4 2014 in Review

Andromeda Capital sold out of Allergan plc (AGN) in Q4 2014, closing a stake of 4,384 shares — an estimated $1.06M sold.

Andromeda Capital first reported a position in AGN in Q3 2014 and held it in 1 quarter. The position peaked at $1.06M in Q3 2014. 840 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Andromeda Capital reported no remaining Allergan plc position as of Q4 2014 after selling out during the quarter.
  • Andromeda Capital sold 4,384 Allergan plc shares in Q4 2014, an estimated $1.06M.
  • Andromeda Capital first reported a position in Allergan plc in Q3 2014 and held it in 1 quarter.
  • Andromeda Capital's Allergan plc position peaked at $1.06M in Q3 2014.
  • 840 funds tracked by Wall St. Rank held Allergan plc as of Q4 2014.

Based on Andromeda Capital's 13F filing for Q4 2014, filed 17 Feb 2015.